IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure

被引:148
作者
Feng, Weiwei [1 ]
Li, Weimin [1 ]
Liu, Wei [1 ]
Wang, Fang [1 ]
Li, Yue [1 ]
Yan, Wei [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin 150001, Heilongjiang, Peoples R China
关键词
Interleukin-17; Isoproterenol-induced heart failure; Myocardial fibrosis; Matrix metalloproteinase; Tissue inhibitor of metalloproteinase; Osteoprotegerin; Receptor activator of nuclear factor-kappa B ligand; Collagens; NF-KAPPA-B; MATRIX METALLOPROTEINASE-3 SECRETION; RECEPTOR ACTIVATOR; INHIBITION; EXPRESSION; LIGAND; INTERLEUKIN-17; MYOFIBROBLASTS; DELETION; AXIS;
D O I
10.1016/j.yexmp.2009.06.001
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective: This study was designed to investigate whether IL-17 can regulate the expression of the MMP/TIMP system, the OPG/RANK/RANKL system, or type-I and type-III collagen fibers in a rat model of isoproterenol-induced heart failure (HF). We also investigated the effect of IL-17 on myocardial fibrosis in this model. Methods: HF was induced in Wistar-Kyoto rats by hypodermic injection of isoproterenol (ISO) twice every 24 h. After 2 months, the surviving rats were divided into three groups: monoclonal Anti-IL-17 Ab (100 mu g/day), IgG (100 mu g/day) or PBS were injected five times every 48 h (i.p.). One day after the last injection, all of the rats were sacrificed. H&E and Masson staining were used to evaluate myocardial fibrosis, and immunohistochemistry was used to measure the levels of MMP-1, TIMP-1, TIMP-4, OPG, RANKL, type-I and type-III collagen fibers. We also treated adult rat cardiac fibroblasts with IL-17 (10 ng/ml), IL-17 (10 ng/ml) + OPG (10 ng/ml), IL-17 (10 ng/ml) + anti-RANKL Ab (100 ng/ml), or PBS for 24 h, realtime RT-PCR was used to measure the expressions of MMP-1. Results: The expressions of MMP-1, RANKL, and type-I and -III collagen fibers decreased, and the expressions of TIMP-1, TIMP-4, and OPG increased in the Anti-IL-17 group compared to controls. H&E and Masson staining revealed that blockade of IL-17 can improve myocardial fibrosis in HE IL-17 increased the expression of MMP-1 in cardiac fibroblasts, and OPG and anti-IL-17 Ab could inhibit this function partly. Thus, IL-17 was dependent on the RANKL/OPG system to induce MMP-1 partly. Conclusion: Our study demonstrates the contribution of IL-17 to myocardial fibrosis in isoproterenol-induced HE IL-17 can regulate the RANKL/OPG and MMP/TIMP systems in this model. The RANKL/OPG system is one of intermediaries between IL-17 and MMP-1 in cardiac fibroblasts. As a harmful cytokine, anti-IL-17 treatment is a potential therapeutic strategy in HF. (C) 2009 Published by Elsevier Inc.
引用
收藏
页码:212 / 218
页数:7
相关论文
共 29 条
[21]   Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways [J].
Miyamoto, M ;
Prause, O ;
Sjöstrand, M ;
Laan, M ;
Lötvall, J ;
Lindén, A .
JOURNAL OF IMMUNOLOGY, 2003, 170 (09) :4665-4672
[22]   Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9 [J].
Romanic, AM ;
Harrison, SM ;
Bao, WK ;
Burns-Kurtis, CL ;
Pickering, S ;
Gu, JL ;
Grau, E ;
Mao, J ;
Sathe, GM ;
Ohlstein, EH ;
Yue, TL .
CARDIOVASCULAR RESEARCH, 2002, 54 (03) :549-558
[23]   Chronic inhibition of nitric oxide synthase induces hypertension and cardiornyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy [J].
Rossi, MA ;
Ramos, SG ;
Prado, CM .
JOURNAL OF HYPERTENSION, 2003, 21 (05) :993-1001
[24]   Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice [J].
Roten, L ;
Nemoto, S ;
Simsic, J ;
Colter, ML ;
Rao, V ;
Baicu, S ;
Defreyte, G ;
Soloway, PJ ;
Zile, MR ;
Spinale, FG .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (01) :109-120
[25]   Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor [J].
Sivasubramanian, N ;
Coker, ML ;
Kurrelmeyer, KM ;
MacLellan, WR ;
DeMayo, FJ ;
Spinale, FG ;
Mann, DL .
CIRCULATION, 2001, 104 (07) :826-831
[26]   Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis [J].
Sonderegger, Ivo ;
Roehn, Till A. ;
Kurrer, Michael O. ;
Iezzi, Giandomenica ;
Zou, Yu ;
Kastelein, Robert A. ;
Bachmann, Martin F. ;
Kopf, Manfred .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (11) :2849-2856
[27]   Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure [J].
Ueland, T ;
Yndestad, A ;
Oie, E ;
Florholmen, G ;
Halvorsen, B ;
Froland, SS ;
Simonsen, S ;
Christensen, G ;
Gullestad, L ;
Aukrust, P .
CIRCULATION, 2005, 111 (19) :2461-2468
[28]   Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction [J].
Vanhoutte, Davy ;
Schellings, Mark W. M. ;
Goette, Martin ;
Swinnen, Melissa ;
Herias, Veronica ;
Wild, Martin K. ;
Vestweber, Dietmar ;
Chorianopoulos, Emmanuel ;
Cortes, Victor ;
Rigotti, Attilio ;
Stepp, Mary-Ann ;
Van de Werf, Frans ;
Carmeliet, Peter ;
Pinto, Yigal M. ;
Heymans, Stephane .
CIRCULATION, 2007, 115 (04) :475-482
[29]   Fibrotic disease and the TH1/TH2 paradigm [J].
Wynn, TA .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (08) :583-594